New Study Confirms Aker BioMarine’s Lysoveta Delivers EPA & DHA to the Brain
As dementia cases are set to triple by 2050, new research points to nutrition as part of the answer(Oslo, April 13, 2026) A new preclinical study demonstrates that Lysoveta delivers EPA and DHA across the brain’s protective barriers. “With a growing burden of brain-related diseases like Alzheimer’s and dementia, research into how nutrition can support brain health has never been more important,” says Matts Johansen, CEO of Aker BioMarine.
Lysoveta is a novel brain health ingredient, consisting of EPA,DHA and Choline in the form of lysophosphatidylcholine This has shown to be the